lindseyporthSep 13, 20201 min readMethotrexate Superior to Sulfasalazine as First-Line csDMARD Monotherapy in Patients With PsAhttps://www.rheumatologyadvisor.com/home/topics/spondyloarthritis/methotrexate-superior-to-sulfasalazine-as-first-line-csdmard-monotherapy-in-psa/
https://www.rheumatologyadvisor.com/home/topics/spondyloarthritis/methotrexate-superior-to-sulfasalazine-as-first-line-csdmard-monotherapy-in-psa/
People with RA are almost twice as likely to develop heart disease as those without the condition.https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/rheumatoid-arthritis-heart-disease
Comments